Her-2 targeting in uterine papillary serous carcinoma

Sumit Talwar; Seth Cohen

doi:10.1016/j.gynor.2012.05.003

Her-2 targeting in uterine papillary serous carcinoma

Gynecol Oncol Case Rep. 2012 May 8;2(3):94-6. doi: 10.1016/j.gynor.2012.05.003. eCollection 2012.

Authors

Sumit Talwar¹, Seth Cohen¹

Affiliation

¹ Department of Hematology/Oncology, St. Luke's Roosevelt Hospital Center, New York, NY, USA.

Abstract

► A case of metastatic uterine papillary serous cancer with Her-2 gene amplification. ► Was treated with a Her-2 targeted agent and achieved durable remission. ► Her-2 targeting should be considered alone or in combination with chemotherapy.

Keywords: Endometrial cancer; Her-2; Papillary serous carcinoma; Targeted therapy.